UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

SCHEDULE 14A
(Rule 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No.   )
 
Filed by the Registrant  [X]
Filed by a Party other than the Registrant [   ]
 
Check the appropriate box:
[   ]           Preliminary Proxy Statement
[   ]           Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
[   ]           Definitive Proxy Statement
[X]           Definitive Additional Materials
[   ]           Soliciting Material Pursuant to Section 240.14a-12

AOXING PHARMACEUTICAL COMPANY, INC.
(Name of Registrant as Specified In Its Charter
 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant
 
Payment of Filing Fee (Check the appropriate box):
 
[X]           No fee required.
[   ]           Fee computed on table below per Exchange Act Rules 14a-6(i) (1) and 0-11.
 
(1)
Title of each class of securities to which transaction applies:                                                                                                                                
 
(2)
Aggregate number of securities to which transaction applies:                                                                                                                                
 
(3)
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
 
(4)
Proposed maximum aggregate value of transaction:                                                                                                                                
 
(5)
Total fee paid:                                                                
 
[   ]           Fee paid previously with preliminary materials.
 
[   ]           Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously.  Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
 
(1)
Amount Previously Paid:                                           
 
(2)
Form, Schedule or Registration Statement No.                                                                                                                     
 
(3)
Filing Party:                                                                                                           
 
(4)
Date Filed:                                                                                                           
 
 
 
 
 
AOXING PHARMACEUTICAL COMPANY, INC.
CONTROL ID:
  
REQUEST ID:
  
 
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS
for the Annual Meeting of Stockholders
 
DATE:
June 23, 2015
 
TIME:
9:30 AM Local Time
 
LOCATION:
No. 1 Nanhuan Eastern Road, Xinle City, Hebei Province, People’s Republic of China
     
HOW TO REQUEST PAPER COPIES OF OUR MATERIALS
 
PHONE:
Call toll free
1-866-752-8683
FAX:
Send this card to
202-521-3464
INTERNET:
https://www.iproxydirect.com/axn
and follow the on-screen instructions.
EMAIL:
proxy@iproxydirect.com.
Include your Control ID in your email.
 
This communication represents a notice to access a more complete set of proxy materials available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting. The proxy statement is available at: https://www.iproxydirect.com/axn
 
If you want to receive a paper copy of the proxy materials you must request one. There is no charge to you for requesting a copy.  To facilitate timely delivery please make the request, as instructed above, before June 5, 2015.
 
 
you may enter your voting instructions at https://www.iproxydirect.com/axn
until 11:59 pm eastern time on june 22, 2015
 
 
The purposes of this meeting are as follows:
  
1.
 
1. To elect directors, each to serve until the next annual meeting of Shareholders or until each successor is duly elected and qualified;
 
2. To ratify the appointment of BDO China Shu Lun Pan Certified Accountants LLP as independent registered public accounting firm of the Company for the fiscal year ending June 30, 2015
 
3. To transact such other business as may properly come before the Annual Meeting and any adjournments or postponements thereof.
 
 
  
Pursuant to new Securities and Exchange Commission rules, you are receiving this Notice that the proxy materials for the Annual meeting are available on the Internet. Follow the instructions above to view the materials and vote or request printed copies.
The board of directors has fixed the close of business on May 1, 2015 as the record date for the determination of stockholders entitled to receive notice of the Annual Meeting and to vote the shares of our common stock, par value $.001 per share, they held on that date at the meeting or any postponement or adjournment of the meeting.
The Board of Directors recommends that you vote ‘for’ all proposals above.
 
Please note – This is not a Proxy Card - you cannot vote by returning this card


 
Aoxing Pharmaceutical Company New (delisted) (AMEX:AXN)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024 Plus de graphiques de la Bourse Aoxing Pharmaceutical Company New (delisted)
Aoxing Pharmaceutical Company New (delisted) (AMEX:AXN)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024 Plus de graphiques de la Bourse Aoxing Pharmaceutical Company New (delisted)